Back
Neurogene 10K Form
Sell
38
NGNE
Neurogene
Last Price:
$21.43
Seasonality Move:
7.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NGNE News And Ratings
See the #1 stock for the next 7 days that we like better than NGNE
NGNE Financial Statistics
Sales & Book Value
| Annual Sales: | $925K |
|---|---|
| Cash Flow: | $-21.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $19.54 |
| Price / Book: | 1.09 |
Profitability
| EPS (TTM): | -4.35000 |
|---|---|
| Net Income (TTM): | $-80.9M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Neurogene Earnings Forecast
Key Neurogene Financial Ratios
-
The Research & Development expenses have been 6,585.62% of Revenue.
-
The Net Earning history of NGNE is -8,123.68% of Total Revenues.
-
Per Share Earnings over the last 4 years have been positive in 1 years.
Neurogene Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NGNE |
| Website: | neurogene.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.17 |
| Quick Ratio: | 11.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |